Human biospecimens, ethically sourced from patients and accompanied by clinical data, are a cornerstone of biomedical research. The value of studying both liquid and solid human biological products lies in their unique characteristics and the direct influence they have on the latest trends in biomedical research.
The Expanding Need for Human Biospecimens Across Research Fields
While oncology has been at the forefront of utilizing biospecimens in biomedical research, other fields are catching up. Areas such as autoimmune disorders and infectious diseases are increasingly recognizing the need for human biological products. The demand for these samples is growing because they offer a wealth of information that can lead to breakthroughs in understanding and treating these conditions.
In this discussion, we will take a look into the key factors driving the increased demand for human biospecimens. We’ll explore their various applications and specifications, as well as some of the main guidelines for handling and working with these vital resources.
Biospecimens: Catalysts for Innovation in Drug and Therapy Development
In recent years, the focus in biopharma has shifted toward precision medicine and therapies based on immunology or genetics. This evolution demands a deeper understanding of the molecular and cellular mechanisms underlying specific diseases. The traditional “one size fits all” approach to treatment is being replaced by more personalized, precision-based therapies tailored to individual patients. The development of these therapies relies heavily on the discovery and validation of new biomarkers and therapeutic targets.
Research in this field has already yielded remarkable results, leading to multiple stratification levels that guide treatment decisions. It is now widely accepted among scientists and clinicians that a particular therapy may be effective for some patients but not for others. In cancer research, for instance, established markers such as HER2 status in breast cancer and EGFR mutation status in lung cancer play a crucial role in selecting the appropriate therapy. The identification of these biomarkers through screening large cohorts of patient-derived samples is essential for validating and establishing new targeted and precision therapies. These therapies include immune-based treatments, cell therapies, vaccines, monoclonal antibodies, and drug-conjugated antibodies.
Despite significant advancements in immuno-oncology and other innovative strategies, a considerable number of patients—who were pre-selected as likely to respond positively to a therapy—experience early or late resistance and relapse. This challenge highlights the need for a deeper understanding of the factors that influence a patient’s response to therapy. Identifying and understanding these mechanisms will depend on the analysis of biospecimens derived directly from patients. Such insights could lead to more effective treatment strategies and better patient outcomes.
Human Biospecimens: A Vital Complement to Other Disease Models
The trends and challenges in translational research underscore the importance of human biological products. According to Pharma Intelligence, there is a significant imbalance in the biopharma market between the resource-intensive research and development phases and the final number of approved and launched drugs. Moreover, a substantial amount of translational research, conducted on cell lines and animal models, often fails to produce reproducible results when applied to humans during early-stage therapy and drug development.
These setbacks in patient care emphasize the importance of incorporating patient-derived materials as early as possible in biomedical research. This approach can help generate meaningful results that might prevent delays in patient care. While animal models and cell lines remain crucial, the trend is shifting toward using primary cell cultures and patient-derived tissues and biofluids.
Human biospecimens offer a direct reflection of the disease in its natural state, providing an unparalleled opportunity to study disease mechanisms, discover new biomarkers, and develop targeted therapies. By analyzing these samples, researchers can gain insights into disease progression, treatment response, and potential resistance mechanisms. This knowledge can accelerate the development of new therapies, ultimately leading to better patient outcomes.
The Ethical Procurement and Future Potential of Human Biospecimens
Ethical considerations are paramount when it comes to procuring human biospecimens. Informed consent, privacy, and the rights of patients must always be respected. When obtained ethically, these samples not only enhance our understanding of diseases but also pave the way for the development of new therapies and diagnostic tools. The future of personalized medicine depends heavily on the continued availability of high-quality human biospecimens. These samples are crucial for the ongoing development of new treatments and for understanding the genetic, molecular, and cellular bases of diseases.
As biomedical research evolves, the role of human biospecimens will become even more significant. Their applications in precision medicine, immunology, oncology, and other fields are expanding rapidly. Researchers are increasingly relying on these samples to drive innovation and improve patient care.
Looking for customized biospecimen collection solutions?
Solomon Park offers tailored biospecimen collection services, supporting biomarker research and ensuring high-quality samples. With our SPRL-StoTrac™ Service, we provide optimal storage and secure shipping for your research needs.
Solomon Park Research Laboratories
For over 30 years, Solomon Park Research Laboratories in Seattle has been dedicated to advancing human health by providing high-quality custom serum and plasma products to laboratories and government agencies worldwide. With a vast database of donors, known lipid and analyte values, and medically trained professionals, Solomon Park offers products and plasma biological services that are nearly identical to human test samples, making them ideal for establishing quality controls, developing standards, and proficiency testing. Their draw center, in collaboration with the CDC, uses a specialized process to ensure the accuracy of their serum and plasma, which are available fresh or frozen. Additionally, Solomon Park offers ultra-low temperature storage for longitudinal studies, with facilities secured by a redundant power source to ensure the integrity of stored samples.
Are you interested in accelerating your research with high-quality human biospecimens? Contact us to learn more about our extensive collections and prospective capabilities. Our team is here to support your research needs and help you make groundbreaking discoveries in the field of biomedical science. Together, we can push the boundaries of what is possible and improve health outcomes for patients worldwide.
